Evaluation of Respiratory Function and Functional Capacity in Pediatric Patients With Chronic Kidney Disease (CKD)

NCT05339997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-07-25

No results posted yet for this study

Summary

Chronic kidney disease (CKD) is defined as a permanent abnormality in kidney structure or function that persists for more than 3 months (for example, glomerular filtration rate \[GFR\] \<60 mL/min/1.73 m2 or albuminuria ≥30 mg/24 hours) and, it effects the 8% to 16% of the population worldwide.In pediatric patients with CKD, exercise capacity begins to decline in stage 3 of the disease and progressively decreases in stage 5, in dialysis and transplant patients (4, 5). Reduction in respiratory muscle strength and six minute walk test (6MWT) is observed in patients with CKD treated with hemodialysis (HD).The aim in present study is to evaluate the relationship between functional capacity and respiratory functions in stage 1-5 pediatric chronic kidney disease patients.

Conditions

  • Chronic Kidney Diseases
  • Chronic Renal Disease
  • Chronic Renal Failure

Interventions

OTHER

6 minute walk test,

submaximal exercise test used to evaluate the functional capacity of patients

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Principal Investigators

  • Irmak Çavuşoğlu, MSc · Acıbadem Mehmet Ali Aydınlar University

  • Elif Esma Safran, MSc · Acıbadem Mehmet Ali Aydınlar University

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2022-06-30
Completion
2022-07-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05339997 on ClinicalTrials.gov